23082110|t|Altered regulation of Akt signaling with murine cerebral malaria, effects on long-term neuro-cognitive function, restoration with lithium treatment.
23082110|a|Neurological and cognitive impairment persist in more than 20% of cerebral malaria (CM) patients long after successful anti-parasitic treatment. We recently reported that long term memory and motor coordination deficits are also present in our experimental cerebral malaria model (ECM). We also documented, in a murine model, a lack of obvious pathology or inflammation after parasite elimination, suggesting that the long-term negative neurological outcomes result from potentially reversible biochemical and physiological changes in brains of ECM mice, subsequent to acute ischemic and inflammatory processes. Here, we demonstrate for the first time that acute ECM results in significantly reduced activation of protein kinase B (PKB or Akt) leading to decreased Akt phosphorylation and inhibition of the glycogen kinase synthase (GSK3beta) in the brains of mice infected with Plasmodium berghei ANKA (PbA) compared to uninfected controls and to mice infected with the non-neurotrophic P. berghei NK65 (PbN). Though Akt activation improved to control levels after chloroquine treatment in PbA-infected mice, the addition of lithium chloride, a compound which inhibits GSK3beta activity and stimulates Akt activation, induced a modest, but significant activation of Akt in the brains of infected mice when compared to uninfected controls treated with chloroquine with and without lithium. In addition, lithium significantly reversed the long-term spatial and visual memory impairment as well as the motor coordination deficits which persisted after successful anti-parasitic treatment. GSK3beta inhibition was significantly increased after chloroquine treatment, both in lithium and non-lithium treated PbA-infected mice. These data indicate that acute ECM is associated with abnormalities in cell survival pathways that result in neuronal damage. Regulation of Akt/GSK3beta with lithium reduces neuronal degeneration and may have neuroprotective effects in ECM. Aberrant regulation of Akt/GSK3beta signaling likely underlies long-term neurological sequelae observed in ECM and may yield adjunctive therapeutic targets for the management of CM.
23082110	22	25	Akt	Gene	11651
23082110	41	47	murine	Species	10090
23082110	48	64	cerebral malaria	Disease	MESH:D016779
23082110	130	137	lithium	Chemical	MESH:D008094
23082110	149	186	Neurological and cognitive impairment	Disease	MESH:D060825
23082110	215	231	cerebral malaria	Disease	MESH:D016779
23082110	233	235	CM	Disease	MESH:D016779
23082110	237	245	patients	Species	9606
23082110	330	368	memory and motor coordination deficits	Disease	MESH:D008569
23082110	406	422	cerebral malaria	Disease	MESH:D016779
23082110	461	467	murine	Species	10090
23082110	506	518	inflammation	Disease	MESH:D007249
23082110	698	702	mice	Species	10090
23082110	724	732	ischemic	Disease	MESH:D002545
23082110	737	749	inflammatory	Disease	MESH:D007249
23082110	881	884	PKB	Gene	11651
23082110	888	891	Akt	Gene	11651
23082110	914	917	Akt	Gene	11651
23082110	982	990	GSK3beta	Gene	56637
23082110	1009	1013	mice	Species	10090
23082110	1028	1046	Plasmodium berghei	Species	5821
23082110	1047	1051	ANKA	Chemical	-
23082110	1053	1056	PbA	Chemical	-
23082110	1097	1101	mice	Species	10090
23082110	1137	1147	P. berghei	Species	5821
23082110	1148	1152	NK65	Chemical	-
23082110	1154	1157	PbN	Chemical	-
23082110	1167	1170	Akt	Gene	11651
23082110	1215	1226	chloroquine	Chemical	MESH:D002738
23082110	1240	1243	PbA	Chemical	-
23082110	1253	1257	mice	Species	10090
23082110	1275	1291	lithium chloride	Chemical	MESH:D018021
23082110	1319	1327	GSK3beta	Gene	56637
23082110	1352	1355	Akt	Gene	11651
23082110	1416	1419	Akt	Gene	11651
23082110	1446	1450	mice	Species	10090
23082110	1501	1512	chloroquine	Chemical	MESH:D002738
23082110	1530	1537	lithium	Chemical	MESH:D008094
23082110	1552	1559	lithium	Chemical	MESH:D008094
23082110	1605	1633	and visual memory impairment	Disease	MESH:D014786
23082110	1649	1676	motor coordination deficits	Disease	MESH:D001259
23082110	1736	1744	GSK3beta	Gene	56637
23082110	1790	1801	chloroquine	Chemical	MESH:D002738
23082110	1821	1828	lithium	Chemical	MESH:D008094
23082110	1837	1844	lithium	Chemical	MESH:D008094
23082110	1853	1856	PbA	Chemical	-
23082110	1866	1870	mice	Species	10090
23082110	1981	1996	neuronal damage	Disease	MESH:D009410
23082110	2012	2015	Akt	Gene	11651
23082110	2016	2024	GSK3beta	Gene	56637
23082110	2030	2037	lithium	Chemical	MESH:D008094
23082110	2046	2067	neuronal degeneration	Disease	MESH:D009410
23082110	2136	2139	Akt	Gene	11651
23082110	2140	2148	GSK3beta	Gene	56637
23082110	2186	2207	neurological sequelae	Disease	MESH:D009422
23082110	2291	2293	CM	Disease	MESH:D016779
23082110	Negative_Correlation	MESH:D008094	MESH:D016779
23082110	Negative_Correlation	MESH:D008094	56637
23082110	Association	11651	56637
23082110	Association	MESH:D009422	56637
23082110	Negative_Correlation	MESH:D008094	MESH:D001259
23082110	Association	MESH:D016779	11651
23082110	Association	MESH:D009410	56637
23082110	Association	MESH:D008094	11651
23082110	Positive_Correlation	MESH:D018021	11651
23082110	Association	MESH:D009422	11651
23082110	Negative_Correlation	MESH:D008094	MESH:D014786
23082110	Positive_Correlation	MESH:D002738	11651
23082110	Negative_Correlation	MESH:D018021	56637
23082110	Negative_Correlation	MESH:D008094	MESH:D009410
23082110	Negative_Correlation	MESH:D002738	56637

